Year |
Citation |
Score |
2023 |
Olsen A, Locascio J, Tuncali I, Laroussi N, Abatzis E, Kamenskaya P, Kuras Y, Yi T, Videnovic A, Hayes M, Ho G, Paulson J, Khurana V, Herrington T, Hyman B, ... ... Growdon J, et al. Health phenome of Parkinson's patients reveals prominent mood-sleep cluster. Research Square. PMID 38196602 DOI: 10.21203/rs.3.rs-3683455/v1 |
0.549 |
|
2023 |
Rajabli F, Benchek P, Tosto G, Kushch N, Sha J, Bazemore K, Zhu C, Lee WP, Haut J, Hamilton-Nelson KL, Wheeler NR, Zhao Y, Farrell JJ, Grunin MA, Leung YY, ... ... Growdon JH, et al. Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies and nominates ancestry-specific loci , , and as novel risk loci for Alzheimer's disease: the Alzheimer's Disease Genetics Consortium. Medrxiv : the Preprint Server For Health Sciences. PMID 37461624 DOI: 10.1101/2023.07.06.23292311 |
0.407 |
|
2021 |
Liu G, Peng J, Liao Z, Locascio JJ, Corvol JC, Zhu F, Dong X, Maple-Grødem J, Campbell MC, Elbaz A, Lesage S, Brice A, Mangone G, Growdon JH, Hung AY, et al. Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease. Nature Genetics. PMID 33958783 DOI: 10.1038/s41588-021-00847-6 |
0.515 |
|
2020 |
Huh YE, Ruby Chiang MS, Locascio JJ, Liao Z, Liu G, Choudhury K, Kuras YI, Tuncali I, Videnovic A, Hunt AL, Schwarzschild MA, Hung AY, Herrington TM, Hayes MT, Hyman BT, ... ... Growdon JH, et al. β-Glucocerebrosidase Activity in -linked Parkinson's Disease: The Type of Mutation Matters. Neurology. PMID 32540937 DOI: 10.1212/Wnl.0000000000009989 |
0.602 |
|
2020 |
Bakshi R, Macklin EA, Hung AY, Hayes MT, Hyman BT, Wills AM, Gomperts SN, Growdon JH, Ascherio A, Scherzer CR, Schwarzschild MA. Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson's Disease in the Harvard Biomarkers Study. Journal of Parkinson's Disease. 10: 505-510. PMID 32250320 DOI: 10.3233/Jpd-191882 |
0.614 |
|
2020 |
Ye R, Touroutoglou A, Brickhouse M, Katz S, Growdon JH, Johnson KA, Dickerson BC, Gomperts SN. Topography of cortical thinning in the Lewy body diseases. Neuroimage. Clinical. 26: 102196. PMID 32059167 DOI: 10.1016/j.nicl.2020.102196 |
0.388 |
|
2019 |
Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, ... ... Growdon JH, et al. Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genetics. PMID 31417202 DOI: 10.1038/s41588-019-0495-7 |
0.412 |
|
2019 |
Shirvan J, Clement N, Ye R, Katz S, Schultz A, Johnson KA, Gomez-Isla T, Frosch M, Growdon JH, Gomperts SN. Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease. Neurology. PMID 31243072 DOI: 10.1212/Wnl.0000000000007855 |
0.309 |
|
2019 |
Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, ... ... Growdon JH, et al. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genetics. 51: 414-430. PMID 30820047 DOI: 10.1038/s41588-019-0358-2 |
0.416 |
|
2019 |
Serrano-Pozo A, Growdon JH. Is Alzheimer's Disease Risk Modifiable? Journal of Alzheimer's Disease : Jad. 67: 795-819. PMID 30776012 DOI: 10.3233/Jad181028 |
0.384 |
|
2017 |
Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, Martin ER, Grenier-Boley B, Heilmann-Heimbach S, Chouraki V, Kuzma AB, ... ... Growdon JH, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature Genetics. PMID 28714976 DOI: 10.1038/Ng.3916 |
0.413 |
|
2017 |
Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, Martin ER, Grenier-Boley B, Heilmann-Heimbach S, Chouraki V, Kuzma AB, ... ... Growdon JH, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature Genetics. PMID 28714976 DOI: 10.1038/Ng.3916 |
0.413 |
|
2016 |
Marquié M, Normandin MD, Meltzer AC, Siao Tick Chong M, Andrea NV, Antón-Fernández A, Klunk WE, Mathis CA, Ikonomovic MD, Debnath M, Bien EA, Vanderburg CR, Costantino I, Makaretz S, DeVos SL, ... ... Growdon JH, et al. Pathologic correlations of [F-18]-AV-1451 imaging in non-Alzheimer tauopathies. Annals of Neurology. PMID 27997036 DOI: 10.1002/Ana.24844 |
0.468 |
|
2016 |
Gomperts SN, Locascio JJ, Makaretz SJ, Schultz A, Caso C, Vasdev N, Sperling R, Growdon JH, Dickerson BC, Johnson K. Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases. Jama Neurology. PMID 27654968 DOI: 10.1001/Jamaneurol.2016.3338 |
0.374 |
|
2016 |
Boeve BF, Dickson DW, Duda JE, Ferman TJ, Galasko DR, Galvin JE, Goldman JG, Growdon JH, Hurtig HI, Kaufer DI, Kantarci K, Leverenz JB, Lippa CF, Lopez OL, McKeith IG, et al. Arguing against the proposed definition changes of PD. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27492190 DOI: 10.1002/Mds.26721 |
0.354 |
|
2016 |
DeKosky ST, Growdon JH. The Human Alzheimer Disease Project: Answering the Call. Jama Neurology. PMID 26831746 DOI: 10.1001/Jamaneurol.2015.4512 |
0.328 |
|
2016 |
Gomperts SN, Marquie M, Locascio JJ, Bayer S, Johnson KA, Growdon JH. PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies. Neuro-Degenerative Diseases. 16: 118-124. PMID 26655867 DOI: 10.1159/000441421 |
0.375 |
|
2015 |
Marquié M, Normandin MD, Vanderburg CR, Costantino IM, Bien EA, Rycyna LG, Klunk WE, Mathis CA, Ikonomovic MD, Debnath ML, Vasdev N, Dickerson BC, Gomperts SN, Growdon JH, Johnson KA, et al. Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Annals of Neurology. PMID 26344059 DOI: 10.1002/Ana.24517 |
0.422 |
|
2015 |
Hyman BT, Growdon JH, Albers MW, Buckner RL, Chhatwal J, Gomez-Isla MT, Haass C, Hudry E, Jack CR, Johnson KA, Khachaturian ZS, Kim DY, Martin JB, Nitsch RM, Rosen BR, et al. Massachusetts Alzheimer's Disease Research Center: Progress and challenges. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26297855 DOI: 10.1016/J.Jalz.2015.06.1887 |
0.631 |
|
2015 |
Locascio JJ, Eberly S, Liao Z, Liu G, Hoesing AN, Duong K, Trisini-Lipsanopoulos A, Dhima K, Hung AY, Flaherty AW, Schwarzschild MA, Hayes MT, Wills AM, Shivraj Sohur U, Mejia NI, ... ... Growdon JH, et al. Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease. Brain : a Journal of Neurology. 138: 2659-71. PMID 26220939 DOI: 10.1093/Brain/Awv202 |
0.641 |
|
2015 |
Wang LS, Naj AC, Graham RR, Crane PK, Kunkle BW, Cruchaga C, Murcia JD, Cannon-Albright L, Baldwin CT, Zetterberg H, Blennow K, Kukull WA, Faber KM, Schupf N, Norton MC, ... ... Growdon JH, et al. Rarity of the Alzheimer disease-protective APP A673T variant in the United States. Jama Neurology. 72: 209-16. PMID 25531812 DOI: 10.1001/Jamaneurol.2014.2157 |
0.52 |
|
2015 |
Locascio JJ, Eberly S, Liao Z, Liu G, Hoesing AN, Duong K, Trisini-Lipsanopoulos A, Dhima K, Hung AY, Flaherty AW, Schwarzschild MA, Hayes MT, Wills AM, Shivraj Sohur U, Mejia NI, ... ... Growdon JH, et al. Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease Brain. 138: 2659-2671. DOI: 10.1093/brain/awv202 |
0.568 |
|
2014 |
Marquie M, Locascio JJ, Rentz DM, Becker JA, Hedden T, Johnson KA, Growdon JH, Gomperts SN. Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an (11)C altropane positron emission tomography study. Alzheimer's Research & Therapy. 6: 52. PMID 25429309 DOI: 10.1186/s13195-014-0052-7 |
0.329 |
|
2014 |
Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS, Kauwe JS, Huentelman MJ, Myers AJ, Bird TD, Boeve BF, ... ... Growdon JH, et al. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. Jama Neurology. 71: 1394-404. PMID 25199842 DOI: 10.1001/Jamaneurol.2014.1491 |
0.478 |
|
2014 |
Serrano-Pozo A, Qian J, Monsell SE, Blacker D, Gómez-Isla T, Betensky RA, Growdon JH, Johnson KA, Frosch MP, Sperling RA, Hyman BT. Mild to moderate Alzheimer dementia with insufficient neuropathological changes. Annals of Neurology. 75: 597-601. PMID 24585367 DOI: 10.1002/Ana.24125 |
0.512 |
|
2014 |
Growdon JH, Hyman BT. APOE genotype and brain development. Jama Neurology. 71: 7-8. PMID 24276019 DOI: 10.1001/Jamaneurol.2013.5200 |
0.52 |
|
2013 |
Santiago JA, Scherzer CR, Potashkin JA, Hyman BT, Ivinson AJ, Trisini-Lipsanopoulos A, Dhima K, Bayer S, Lockhart KC, Yi T, Liao Z, Hoesing AN, Duong K, Roderick S, Sudarsky LR, ... ... Growdon JH, et al. Specific splice variants are associated with Parkinson's disease Movement Disorders. 28: 1724-1727. PMID 24108702 DOI: 10.1002/mds.25635 |
0.404 |
|
2013 |
Ding H, Dhima K, Lockhart KC, Locascio JJ, Hoesing AN, Duong K, Trisini-Lipsanopoulos A, Hayes MT, Sohur US, Wills AM, Mollenhauer B, Flaherty AW, Hung AY, Mejia N, Khurana V, ... ... Growdon JH, et al. Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study. Neurology. 81: 1531-7. PMID 24068787 DOI: 10.1212/Wnl.0B013E3182A95818 |
0.593 |
|
2013 |
Serrano-Pozo A, Muzikansky A, Gómez-Isla T, Growdon JH, Betensky RA, Frosch MP, Hyman BT. Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 72: 462-71. PMID 23656989 DOI: 10.1097/Nen.0B013E3182933788 |
0.499 |
|
2013 |
Serrano-Pozo A, Gómez-Isla T, Growdon JH, Frosch MP, Hyman BT. A phenotypic change but not proliferation underlies glial responses in Alzheimer disease. The American Journal of Pathology. 182: 2332-44. PMID 23602650 DOI: 10.1016/J.Ajpath.2013.02.031 |
0.52 |
|
2013 |
Gomperts SN, Johnson KA, Growdon J. Reply: Beyond the limits of detection: failure of PiB imaging to capture true Aβ burden. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 407. PMID 23401107 DOI: 10.1002/mds.25309 |
0.366 |
|
2013 |
Gomperts SN, Locascio JJ, Rentz D, Santarlasci A, Marquie M, Johnson KA, Growdon JH. Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia. Neurology. 80: 85-91. PMID 23243071 DOI: 10.1212/WNL.0b013e31827b1a07 |
0.336 |
|
2013 |
Ziegler DA, Wonderlick JS, Ashourian P, Hansen LA, Young JC, Murphy AJ, Koppuzha CK, Growdon JH, Corkin S. Substantia nigra volume loss before basal forebrain degeneration in early Parkinson disease. Jama Neurology. 70: 241-7. PMID 23183921 DOI: 10.1001/jamaneurol.2013.597 |
0.324 |
|
2012 |
Serrano-Pozo A, Mielke ML, Muzitansky A, Gómez-Isla T, Growdon JH, Bacskai BJ, Betensky RA, Frosch MP, Hyman BT. Stable size distribution of amyloid plaques over the course of Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 71: 694-701. PMID 22805771 DOI: 10.1097/Nen.0B013E31825E77De |
0.523 |
|
2012 |
Allen M, Zou F, Chai HS, Younkin CS, Crook J, Pankratz VS, Carrasquillo MM, Rowley CN, Nair AA, Middha S, Maharjan S, Nguyen T, Ma L, Malphrus KG, Palusak R, ... ... Growdon JH, et al. Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology. 79: 221-8. PMID 22722634 DOI: 10.1212/Wnl.0B013E3182605801 |
0.386 |
|
2012 |
Gomperts SN, Locascio JJ, Marquie M, Santarlasci AL, Rentz DM, Maye J, Johnson KA, Growdon JH. Brain amyloid and cognition in Lewy body diseases. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 965-73. PMID 22693110 DOI: 10.1002/Mds.25048 |
0.381 |
|
2011 |
Ding H, Sarokhan AK, Roderick SS, Bakshi R, Maher NE, Ashourian P, Kan CG, Chang S, Santarlasci A, Swords KE, Ravina BM, Hayes MT, Sohur US, Wills AM, Flaherty AW, ... ... Growdon JH, et al. Association of SNCA with Parkinson: replication in the Harvard NeuroDiscovery Center Biomarker Study. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2283-6. PMID 21953863 DOI: 10.1002/Mds.23934 |
0.64 |
|
2011 |
Serrano-Pozo A, Mielke ML, Gómez-Isla T, Betensky RA, Growdon JH, Frosch MP, Hyman BT. Reactive glia not only associates with plaques but also parallels tangles in Alzheimer's disease. The American Journal of Pathology. 179: 1373-84. PMID 21777559 DOI: 10.1016/J.Ajpath.2011.05.047 |
0.534 |
|
2011 |
Growdon JH, Hyman BT. Plasma beta-amyloid linked to cognitive decline. Archives of Neurology. 68: 799-801. PMID 21670404 DOI: 10.1001/Archneurol.2011.114 |
0.432 |
|
2011 |
Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, Larson EB, Bird TD, Boeve BF, Graff-Radford NR, De Jager PL, ... ... Growdon JH, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nature Genetics. 43: 436-41. PMID 21460841 DOI: 10.1038/Ng.801 |
0.424 |
|
2011 |
Skoglund L, Matsui T, Freeman SH, Wallin A, Blom ES, Frosch MP, Growdon JH, Hyman BT, Lannfelt L, Ingelsson M, Glaser A. Novel progranulin mutation detected in 2 patients with FTLD. Alzheimer Disease and Associated Disorders. 25: 173-8. PMID 20975516 DOI: 10.1097/Wad.0B013E3181Fbc22C |
0.399 |
|
2010 |
Serrano-Pozo A, Vega GL, Lütjohann D, Locascio JJ, Tennis MK, Deng A, Atri A, Hyman BT, Irizarry MC, Growdon JH. Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers. Alzheimer Disease and Associated Disorders. 24: 220-6. PMID 20473136 DOI: 10.1097/Wad.0B013E3181D61Fea |
0.523 |
|
2010 |
Serrano-Pozo A, William CM, Ferrer I, Uro-Coste E, Delisle MB, Maurage CA, Hock C, Nitsch RM, Masliah E, Growdon JH, Frosch MP, Hyman BT. Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology. Brain : a Journal of Neurology. 133: 1312-27. PMID 20360050 DOI: 10.1093/Brain/Awq056 |
0.637 |
|
2010 |
Salat DH, Tuch DS, van der Kouwe AJ, Greve DN, Pappu V, Lee SY, Hevelone ND, Zaleta AK, Growdon JH, Corkin S, Fischl B, Rosas HD. White matter pathology isolates the hippocampal formation in Alzheimer's disease. Neurobiology of Aging. 31: 244-56. PMID 18455835 DOI: 10.1016/J.Neurobiolaging.2008.03.013 |
0.335 |
|
2009 |
Skoglund L, Ingvast S, Matsui T, Freeman SH, Frosch MP, Brundin R, Giedraitis V, Growdon JH, Hyman BT, Lannfelt L, Ingelsson M, Glaser A. No evidence of PGRN or MAPT gene dosage alterations in a collection of patients with frontotemporal lobar degeneration. Dementia and Geriatric Cognitive Disorders. 28: 471-5. PMID 19940479 DOI: 10.1159/000260046 |
0.48 |
|
2009 |
Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, Grodstein F, Wright CI, Blacker D, Rosas HD, Sperling RA, Atri A, Growdon JH, Hyman BT, Morris JC, et al. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cerebral Cortex (New York, N.Y. : 1991). 19: 497-510. PMID 18632739 DOI: 10.1093/Cercor/Bhn113 |
0.508 |
|
2008 |
Latourelle JC, Sun M, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, Shill HA, et al. The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. Bmc Medicine. 6: 32. PMID 18986508 DOI: 10.1186/1741-7015-6-32 |
0.559 |
|
2008 |
Grodstein F, van Oijen M, Irizarry MC, Rosas HD, Hyman BT, Growdon JH, De Vivo I. Shorter telomeres may mark early risk of dementia: preliminary analysis of 62 participants from the nurses' health study. Plos One. 3: e1590. PMID 18795148 DOI: 10.1371/Journal.Pone.0001590 |
0.455 |
|
2008 |
Gomperts SN, Rentz DM, Moran E, Becker JA, Locascio JJ, Klunk WE, Mathis CA, Elmaleh DR, Shoup T, Fischman AJ, Hyman BT, Growdon JH, Johnson KA. Imaging amyloid deposition in Lewy body diseases. Neurology. 71: 903-10. PMID 18794492 DOI: 10.1212/01.Wnl.0000326146.60732.D6 |
0.535 |
|
2008 |
McNicoll CF, Latourelle JC, MacDonald ME, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, et al. Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1596-601. PMID 18649400 DOI: 10.1002/Mds.22186 |
0.579 |
|
2008 |
DeStefano AL, Latourelle J, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts R, Guttman M, Racette BA, Perlmutter JS, Marlor L, Shill HA, et al. Replication of association between ELAVL4 and Parkinson disease: the GenePD study. Human Genetics. 124: 95-9. PMID 18587682 DOI: 10.1007/S00439-008-0526-4 |
0.57 |
|
2008 |
Atri A, Shaughnessy LW, Locascio JJ, Growdon JH. Long-term course and effectiveness of combination therapy in Alzheimer disease. Alzheimer Disease and Associated Disorders. 22: 209-21. PMID 18580597 DOI: 10.1097/WAD.0b013e31816653bc |
0.318 |
|
2008 |
Locascio JJ, Fukumoto H, Yap L, Bottiglieri T, Growdon JH, Hyman BT, Irizarry MC. Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease. Archives of Neurology. 65: 776-85. PMID 18541797 DOI: 10.1001/Archneur.65.6.776 |
0.502 |
|
2008 |
Tobin JE, Latourelle JC, Lew MF, Klein C, Suchowersky O, Shill HA, Golbe LI, Mark MH, Growdon JH, Wooten GF, Racette BA, Perlmutter JS, Watts R, Guttman M, Baker KB, et al. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology. 71: 28-34. PMID 18509094 DOI: 10.1212/01.Wnl.0000304051.01650.23 |
0.528 |
|
2008 |
Freeman SH, Spires-Jones T, Hyman BT, Growdon JH, Frosch MP. TAR-DNA binding protein 43 in Pick disease. Journal of Neuropathology and Experimental Neurology. 67: 62-7. PMID 18091558 DOI: 10.1097/Nen.0B013E3181609361 |
0.486 |
|
2007 |
Irizarry MC, Yao Y, Hyman BT, Growdon JH, Praticò D. Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease. Neuro-Degenerative Diseases. 4: 403-5. PMID 17934322 DOI: 10.1159/000107699 |
0.523 |
|
2007 |
Ingelsson M, Ramasamy K, Russ C, Freeman SH, Orne J, Raju S, Matsui T, Growdon JH, Frosch MP, Ghetti B, Brown RH, Irizarry MC, Hyman BT. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains. Acta Neuropathologica. 114: 471-9. PMID 17721707 DOI: 10.1007/S00401-007-0280-Z |
0.478 |
|
2007 |
Bacskai BJ, Frosch MP, Freeman SH, Raymond SB, Augustinack JC, Johnson KA, Irizarry MC, Klunk WE, Mathis CA, Dekosky ST, Greenberg SM, Hyman BT, Growdon JH. Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Archives of Neurology. 64: 431-4. PMID 17353389 DOI: 10.1001/Archneur.64.3.431 |
0.475 |
|
2007 |
Scherzer CR, Eklund AC, Morse LJ, Liao Z, Locascio JJ, Fefer D, Schwarzschild MA, Schlossmacher MG, Hauser MA, Vance JM, Sudarsky LR, Standaert DG, Growdon JH, Jensen RV, Gullans SR. Molecular markers of early Parkinson's disease based on gene expression in blood. Proceedings of the National Academy of Sciences of the United States of America. 104: 955-60. PMID 17215369 DOI: 10.1073/Pnas.0610204104 |
0.555 |
|
2006 |
Wilk JB, Tobin JE, Suchowersky O, Shill HA, Klein C, Wooten GF, Lew MF, Mark MH, Guttman M, Watts RL, Singer C, Growdon JH, Latourelle JC, Saint-Hilaire MH, DeStefano AL, et al. Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study. Neurology. 67: 2206-10. PMID 17190945 DOI: 10.1212/01.Wnl.0000249149.22407.D1 |
0.511 |
|
2006 |
Hyman BT, Growdon JH. Can the immune system fight Alzheimer disease? Nature Medicine. 12: 755-6; discussion 75. PMID 16829929 DOI: 10.1038/Nm0706-755 |
0.462 |
|
2006 |
Ingelsson M, Ramasamy K, Cantuti-Castelvetri I, Skoglund L, Matsui T, Orne J, Kowa H, Raju S, Vanderburg CR, Augustinack JC, de Silva R, Lees AJ, Lannfelt L, Growdon JH, Frosch MP, et al. No alteration in tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer's disease brain. Acta Neuropathologica. 112: 439-49. PMID 16802167 DOI: 10.1007/S00401-006-0095-3 |
0.496 |
|
2006 |
Sun M, Latourelle JC, Wooten GF, Lew MF, Klein C, Shill HA, Golbe LI, Mark MH, Racette BA, Perlmutter JS, Parsian A, Guttman M, Nicholson G, Xu G, Wilk JB, ... ... Growdon JH, et al. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Archives of Neurology. 63: 826-32. PMID 16769863 DOI: 10.1001/Archneur.63.6.826 |
0.553 |
|
2006 |
Klucken J, Ingelsson M, Shin Y, Irizarry MC, Hedley-Whyte ET, Frosch M, Growdon J, McLean P, Hyman BT. Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies. Acta Neuropathologica. 111: 101-8. PMID 16482476 DOI: 10.1007/S00401-005-0027-7 |
0.64 |
|
2006 |
Lleó A, Greenberg SM, Growdon JH. Current pharmacotherapy for Alzheimer's disease. Annual Review of Medicine. 57: 513-33. PMID 16409164 DOI: 10.1146/annurev.med.57.121304.131442 |
0.401 |
|
2005 |
Growdon JH. Commentary on "Diagnosis of Alzheimer's disease: two decades of progress." The NIA's Alzheimer Disease Centers. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 1: 101. PMID 19595834 DOI: 10.1016/j.jalz.2005.09.012 |
0.372 |
|
2005 |
Atri A, Locascio JJ, Lin JM, Yap L, Dickerson BC, Grodstein F, Irizarry MC, Growdon JH, Greenberg SM. Prevalence and effects of lobar microhemorrhages in early-stage dementia. Neuro-Degenerative Diseases. 2: 305-12. PMID 16909013 DOI: 10.1159/000092317 |
0.347 |
|
2005 |
Irizarry MC, Gurol ME, Raju S, Diaz-Arrastia R, Locascio JJ, Tennis M, Hyman BT, Growdon JH, Greenberg SM, Bottiglieri T. Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease. Neurology. 65: 1402-8. PMID 16275827 DOI: 10.1212/01.Wnl.0000183063.99107.5C |
0.469 |
|
2005 |
Karamohamed S, Golbe LI, Mark MH, Lazzarini AM, Suchowersky O, Labelle N, Guttman M, Currie LJ, Wooten GF, Stacy M, Saint-Hilaire M, Feldman RG, Liu J, Shoemaker CM, Wilk JB, ... ... Growdon J, et al. Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 1188-91. PMID 15966003 DOI: 10.1002/Mds.20515 |
0.539 |
|
2004 |
Alberici A, Gobbo C, Panzacchi A, Nicosia F, Ghidoni R, Benussi L, Hock C, Papassotiropoulos A, Liberini P, Growdon JH, Frisoni GB, Villa A, Zanetti O, Cappa S, Fazio F, et al. Frontotemporal dementia: impact of P301L tau mutation on a healthy carrier. Journal of Neurology, Neurosurgery, and Psychiatry. 75: 1607-10. PMID 15489396 DOI: 10.1136/Jnnp.2003.021295 |
0.393 |
|
2004 |
Ingelsson M, Fukumoto H, Newell KL, Growdon JH, Hedley-Whyte ET, Frosch MP, Albert MS, Hyman BT, Irizarry MC. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology. 62: 925-31. PMID 15037694 DOI: 10.1212/01.Wnl.0000115115.98960.37 |
0.466 |
|
2004 |
Kensinger EA, Anderson A, Growdon JH, Corkin S. Effects of Alzheimer disease on memory for verbal emotional information. Neuropsychologia. 42: 791-800. PMID 15037057 DOI: 10.1016/j.neuropsychologia.2003.11.011 |
0.302 |
|
2004 |
Lleó A, Berezovska O, Growdon JH, Hyman BT. Clinical, pathological, and biochemical spectrum of Alzheimer disease associated with PS-1 mutations. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 12: 146-56. PMID 15010344 DOI: 10.1097/00019442-200403000-00006 |
0.514 |
|
2004 |
Fox N, Growdon JH. Biomarkers and Surrogates Neurorx. 1: 181. DOI: 10.1602/Neurorx.1.2.181 |
0.363 |
|
2004 |
Ingelsson M, Cantuti-Castelvetri I, Ramasamy K, Orne JD, Augustinack JC, Vanderburg CR, Growdon JH, Frosch MP, Irizarry MC, Standaert DG, Hyman BT. P3-229 Analysis of gene expression in the Alzheimer's disease brain Neurobiology of Aging. 25: S420. DOI: 10.1016/S0197-4580(04)81379-4 |
0.499 |
|
2003 |
Karamohamed S, DeStefano AL, Wilk JB, Shoemaker CM, Golbe LI, Mark MH, Lazzarini AM, Suchowersky O, Labelle N, Guttman M, Currie LJ, Wooten GF, Stacy M, Saint-Hilaire M, Feldman RG, ... ... Growdon J, et al. A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study. Neurology. 61: 1557-61. PMID 14663042 DOI: 10.1212/01.Wnl.0000095966.99430.F4 |
0.566 |
|
2003 |
Fukumoto H, Tennis M, Locascio JJ, Hyman BT, Growdon JH, Irizarry MC. Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels. Archives of Neurology. 60: 958-64. PMID 12873852 DOI: 10.1001/Archneur.60.7.958 |
0.504 |
|
2003 |
Kensinger EA, Shearer DK, Locascio JJ, Growdon JH, Corkin S. Working memory in mild Alzheimer's disease and early Parkinson's disease. Neuropsychology. 17: 230-9. PMID 12803428 DOI: 10.1037/0894-4105.17.2.230 |
0.406 |
|
2003 |
Zhukareva V, Sundarraj S, Mann D, Sjogren M, Blenow K, Clark CM, McKeel DW, Goate A, Lippa CF, Vonsattel JP, Growdon JH, Trojanowski JQ, Lee VM. Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study. Acta Neuropathologica. 105: 469-76. PMID 12677447 DOI: 10.1007/S00401-002-0668-8 |
0.361 |
|
2003 |
Locascio JJ, Corkin S, Growdon JH. Relation between clinical characteristics of Parkinson's disease and cognitive decline. Journal of Clinical and Experimental Neuropsychology. 25: 94-109. PMID 12607175 DOI: 10.1076/jcen.25.1.94.13624 |
0.337 |
|
2002 |
DeStefano AL, Lew MF, Golbe LI, Mark MH, Lazzarini AM, Guttman M, Montgomery E, Waters CH, Singer C, Watts RL, Currie LJ, Wooten GF, Maher NE, Wilk JB, Sullivan KM, ... ... Growdon JH, et al. PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study. American Journal of Human Genetics. 70: 1089-95. PMID 11920285 DOI: 10.1086/339814 |
0.566 |
|
2002 |
Maher NE, Golbe LI, Lazzarini AM, Mark MH, Currie LJ, Wooten GF, Saint-Hilaire M, Wilk JB, Volcjak J, Maher JE, Feldman RG, Guttman M, Lew M, Waters CH, Schuman S, ... ... Growdon J, et al. Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study. Neurology. 58: 79-84. PMID 11781409 DOI: 10.1212/Wnl.58.1.79 |
0.571 |
|
2001 |
Growdon JH. Incorporating biomarkers into clinical drug trials in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 3: 287-292. PMID 12214049 DOI: 10.3233/Jad-2001-3303 |
0.382 |
|
2001 |
DeStefano AL, Golbe LI, Mark MH, Lazzarini AM, Maher NE, Saint-Hilaire M, Feldman RG, Guttman M, Watts RL, Suchowersky O, Lafontaine AL, Labelle N, Lew MF, Waters CH, Growdon JH, et al. Genome-wide scan for Parkinson's disease: the GenePD Study. Neurology. 57: 1124-6. PMID 11571351 DOI: 10.1212/Wnl.57.6.1124 |
0.557 |
|
2001 |
Deng A, Irizarry MC, Nitsch RM, Growdon JH, Rebeck GW. Elevation of cystatin C in susceptible neurons in Alzheimer's disease. The American Journal of Pathology. 159: 1061-8. PMID 11549598 DOI: 10.1016/S0002-9440(10)61781-6 |
0.559 |
|
2001 |
Clarke RJ, Parker AJ, Kensinger EA, Growdon JH, Corkin S. Neuroanatomical correlates of semantic memory impairment seen in normal aging and early Alzheimer's disease, as measured by functional MRI Neuroimage. 13: 650. DOI: 10.1016/S1053-8119(01)91993-7 |
0.343 |
|
2000 |
Hock C, Maddalena A, Heuser I, Naber D, Oertel W, von der Kammer H, Wienrich M, Raschig A, Deng M, Growdon JH, Nitsch RM. Treatment with the selective muscarinic agonist talsaclidine decreases cerebrospinal fluid levels of total amyloid beta-peptide in patients with Alzheimer's disease. Annals of the New York Academy of Sciences. 920: 285-91. PMID 11193166 DOI: 10.1111/J.1749-6632.2000.Tb06937.X |
0.571 |
|
2000 |
Nitsch RM, Deng M, Tennis M, Schoenfeld D, Growdon JH. The selective muscarinic M1 agonist AF102B decreases levels of total Abeta in cerebrospinal fluid of patients with Alzheimer's disease. Annals of Neurology. 48: 913-8. PMID 11117548 DOI: 10.1002/1531-8249(200012)48:6<913::Aid-Ana12>3.0.Co;2-S |
0.592 |
|
2000 |
Finckh U, von der Kammer H, Velden J, Michel T, Andresen B, Deng A, Zhang J, Müller-Thomsen T, Zuchowski K, Menzer G, Mann U, Papassotiropoulos A, Heun R, Zurdel J, Holst F, ... ... Growdon JH, et al. Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease. Archives of Neurology. 57: 1579-83. PMID 11074789 DOI: 10.1001/Archneur.57.11.1579 |
0.653 |
|
2000 |
Ellis T, Cudkowicz ME, Sexton PM, Growdon JH. Clozapine and risperidone treatment of psychosis in Parkinson's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 12: 364-9. PMID 10956570 DOI: 10.1176/appi.neuropsych.12.3.364 |
0.322 |
|
2000 |
Binetti G, Locascio JJ, Corkin S, Vonsattel JP, Growdon JH. Differences between Pick disease and Alzheimer disease in clinical appearance and rate of cognitive decline. Archives of Neurology. 57: 225-32. PMID 10681082 DOI: 10.1001/Archneur.57.2.225 |
0.372 |
|
2000 |
Greenberg SM, Tennis MK, Brown LB, Gomez-Isla T, Hayden DL, Schoenfeld DA, Walsh KL, Corwin C, Daffner KR, Friedman P, Meadows ME, Sperling RA, Growdon JH. Donepezil therapy in clinical practice: a randomized crossover study. Archives of Neurology. 57: 94-9. PMID 10634454 DOI: 10.1001/Archneur.57.1.94 |
0.333 |
|
2000 |
Growdon JH. CNS biomarkers for Alzheimer's disease Neurobiology of Aging. 21: 208. DOI: 10.1016/S0197-4580(00)83263-7 |
0.392 |
|
2000 |
Growdon JH, Wurtman RJ, Corkin S, Nitsch RM. The molecular basis of dementia: Preface Annals of the New York Academy of Sciences. 920: xi-xii. |
0.446 |
|
1999 |
Gasparini L, Ghidoni R, Alberici AC, Benussi L, Moratto D, Trabucchi M, Growdon JH, Nitsch RM, Binetti G. Modulation of presenilin-1 processing by nitric oxide during apoptosis induced by serum withdrawal and glucose deprivation. Annals of the New York Academy of Sciences. 893: 294-7. PMID 10672252 DOI: 10.1111/J.1749-6632.1999.Tb07840.X |
0.453 |
|
1999 |
Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 58: 1147-55. PMID 10560657 DOI: 10.1097/00005072-199911000-00004 |
0.467 |
|
1999 |
Gómez-Tortosa E, Newell K, Irizarry MC, Albert M, Growdon JH, Hyman BT. Clinical and quantitative pathologic correlates of dementia with Lewy bodies. Neurology. 53: 1284-91. PMID 10522886 DOI: 10.1212/Wnl.53.6.1284 |
0.497 |
|
1999 |
Alberici A, Moratto D, Benussi L, Gasparini L, Ghidoni R, Gatta LB, Finazzi D, Frisoni GB, Trabucchi M, Growdon JH, Nitsch RM, Binetti G. Presenilin 1 protein directly interacts with Bcl-2. The Journal of Biological Chemistry. 274: 30764-9. PMID 10521466 DOI: 10.1074/Jbc.274.43.30764 |
0.513 |
|
1999 |
Solomon PR, Adams FA, Groccia ME, DeVeaux R, Growdon JH, Pendlebury WW. Correlational analysis of five commonly used measures of mental status/functional abilities in patients with Alzheimer disease. Alzheimer Disease and Associated Disorders. 13: 147-50. PMID 10485573 DOI: 10.1097/00002093-199907000-00006 |
0.343 |
|
1999 |
Irizarry MC, Ghaemi SN, Lee-Cherry ER, Gomez-Isla T, Binetti G, Hyman BT, Growdon JH. Risperidone treatment of behavioral disturbances in outpatients with dementia. The Journal of Neuropsychiatry and Clinical Neurosciences. 11: 336-42. PMID 10440009 DOI: 10.1176/Jnp.11.3.336 |
0.429 |
|
1999 |
Growdon JH. Biomarkers of Alzheimer disease. Archives of Neurology. 56: 281-3. PMID 10190817 DOI: 10.1001/Archneur.56.3.281 |
0.379 |
|
1998 |
Wurtman J, Wurtman R, Mark S, Tsay R, Gilbert W, Growdon J. d-Fenfluramine selectively suppresses carbohydrate snacking by obese subjects. The International Journal of Eating Disorders. 4: 89-99. PMID 11540865 DOI: 10.1002/1098-108X(198502)4:1<89::AID-EAT2260040110>3.0.CO;2-D |
0.41 |
|
1998 |
Liao A, Nitsch RM, Greenberg SM, Finckh U, Blacker D, Albert M, Rebeck GW, Gomez-Isla T, Clatworthy A, Binetti G, Hock C, Mueller-Thomsen T, Mann U, Zuchowski K, Beisiegel U, ... ... Growdon JH, et al. Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. Human Molecular Genetics. 7: 1953-6. PMID 9811940 DOI: 10.1093/Hmg/7.12.1953 |
0.599 |
|
1998 |
Growdon JH. Apolipoprotein E and Alzheimer disease. Archives of Neurology. 55: 1053-4. PMID 9708953 DOI: 10.1001/archneur.55.8.1053 |
0.357 |
|
1998 |
Growdon JH. To tap or not to tap: cerebrospinal fluid biomarkers of Alzheimer's disease. Annals of Neurology. 44: 6-7. PMID 9667586 DOI: 10.1002/ana.410440105 |
0.367 |
|
1998 |
Trojanowski JQ, Growdon JH. A new consensus report on biomarkers for the early antemortem diagnosis of Alzheimer disease: current status, relevance to drug discovery, and recommendations for future research. Journal of Neuropathology and Experimental Neurology. 57: 643-4. PMID 9630242 DOI: 10.1097/00005072-199806000-00010 |
0.307 |
|
1998 |
Silver M, Newell K, Hyman B, Growdon J, Hedley-Whyte ET, Perls T. Unraveling the mystery of cognitive changes in old age: correlation of neuropsychological evaluation with neuropathological findings in the extreme old. International Psychogeriatrics / Ipa. 10: 25-41. PMID 9629522 DOI: 10.1017/S1041610298005122 |
0.52 |
|
1998 |
Growdon JH, Kieburtz K, McDermott MP, Panisset M, Friedman JH. Levodopa improves motor function without impairing cognition in mild non-demented Parkinson's disease patients. Parkinson Study Group. Neurology. 50: 1327-31. PMID 9595982 DOI: 10.1212/Wnl.50.5.1327 |
0.308 |
|
1998 |
Hock C, Drasch G, Golombowski S, Müller-Spahn F, Willershausen-Zönnchen B, Schwarz P, Hock U, Growdon JH, Nitsch RM. Increased blood mercury levels in patients with Alzheimer's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 105: 59-68. PMID 9588761 DOI: 10.1007/s007020050038 |
0.587 |
|
1998 |
Nitsch RM, Kim C, Growdon JH. Vasopressin and bradykinin regulate secretory processing of the amyloid protein precursor of Alzheimer's disease. Neurochemical Research. 23: 807-14. PMID 9566621 DOI: 10.1023/A:1022423813362 |
0.557 |
|
1998 |
Davies P, Resnick J, Resnick B, Gilman S, Growdon JH, Khachaturian ZS, Radebaugh TS, Roses AD, Selkoe DJ, Trojanowski JQ, Blass JP, Gibson GE, Sheu KFR, Blennow K, Delacourte A, et al. Consensus report of the working group on: 'Molecular and biochemical markers of Alzheimer's disease' Neurobiology of Aging. 19: 109-116. PMID 9558143 DOI: 10.1016/S0197-4580(98)00022-0 |
0.532 |
|
1998 |
Hock C, Golombowski S, Müller-Spahn F, Naser W, Beyreuther K, Mönning U, Schenk D, Vigo-Pelfrey C, Bush AM, Moir R, Tanzi RE, Growdon JH, Nitsch RM. Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity. European Neurology. 39: 111-8. PMID 9520072 DOI: 10.1159/000007917 |
0.59 |
|
1998 |
Rebeck GW, Alonzo NC, Berezovska O, Harr SD, Knowles RB, Growdon JH, Hyman BT, Mendez AJ. Structure and functions of human cerebrospinal fluid lipoproteins from individuals of different APOE genotypes. Experimental Neurology. 149: 175-82. PMID 9454626 DOI: 10.1006/Exnr.1997.6710 |
0.429 |
|
1997 |
Ullman MT, Corkin S, Coppola M, Hickok G, Growdon JH, Koroshetz WJ, Pinker S. A Neural Dissociation within Language: Evidence that the Mental Dictionary Is Part of Declarative Memory, and that Grammatical Rules Are Processed by the Procedural System. Journal of Cognitive Neuroscience. 9: 266-76. PMID 23962016 DOI: 10.1162/Jocn.1997.9.2.266 |
0.3 |
|
1997 |
Growdon JH, Graefe K, Tennis M, Hayden D, Schoenfeld D, Wray SH. Pupil dilation to tropicamide is not specific for Alzheimer disease. Archives of Neurology. 54: 841-4. PMID 9236572 DOI: 10.1001/Archneur.1997.00550190031011 |
0.357 |
|
1997 |
Nitsch RM, Deng A, Wurtman RJ, Growdon JH. Metabotropic glutamate receptor subtype mGluR1alpha stimulates the secretion of the amyloid beta-protein precursor ectodomain. Journal of Neurochemistry. 69: 704-12. PMID 9231730 DOI: 10.1046/j.1471-4159.1997.69020704.x |
0.607 |
|
1997 |
Gómez-Isla T, Wasco W, Pettingell WP, Gurubhagavatula S, Schmidt SD, Jondro PD, McNamara M, Rodes LA, DiBlasi T, Growdon WB, Seubert P, Schenk D, Growdon JH, Hyman BT, Tanzi RE. A novel presenilin-1 mutation: increased beta-amyloid and neurofibrillary changes. Annals of Neurology. 41: 809-13. PMID 9189043 DOI: 10.1002/Ana.410410618 |
0.469 |
|
1997 |
Scott WK, Yamaoka LH, Locke PA, Rosi BL, Gaskell PC, Saunders AM, Conneally PM, Small GW, Farrer LA, Growdon JH, Roses AD, Pericak-Vance MA, Haines JL. No association or linkage between an intronic polymorphism of presenilin-1 and sporadic or late-onset familial Alzheimer disease. Genetic Epidemiology. 14: 307-15. PMID 9181359 DOI: 10.1002/(Sici)1098-2272(1997)14:3<307::Aid-Gepi8>3.0.Co;2-1 |
0.36 |
|
1997 |
Growdon JH. Muscarinic agonists in Alzheimer's disease. Life Sciences. 60: 993-8. PMID 9121366 DOI: 10.1016/S0024-3205(97)00039-8 |
0.354 |
|
1997 |
Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. The New England Journal of Medicine. 336: 1216-22. PMID 9110909 DOI: 10.1056/Nejm199704243361704 |
0.357 |
|
1997 |
Gómez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE, Hyman BT. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Annals of Neurology. 41: 17-24. PMID 9005861 DOI: 10.1002/Ana.410410106 |
0.487 |
|
1997 |
Newell K, Hyman B, Growdon J, Hedlev-Whyte ET. EVALUATION OF NIA-REAGAN INSTITUTE CRITERIA FOR THE NEUROPATHOLOGICAL DIAGNOSIS OF ALZHEIMER DISEASE Journal of Neuropathology and Experimental Neurology. 56: 593. DOI: 10.1097/00005072-199705000-00100 |
0.491 |
|
1996 |
Postle BR, Corkin S, Growdon JH. Intact implicit memory for novel patterns in Alzheimer's disease. Learning & Memory (Cold Spring Harbor, N.Y.). 3: 305-12. PMID 10456100 DOI: 10.1101/Lm.3.4.305 |
0.326 |
|
1996 |
Haines JL, Pritchard ML, Saunders AM, Schildkraut JM, Growdon JH, Gaskell PC, Farrer LA, Auerbach SA, Gusella JF, Locke PA, Rosi BL, Yamaoka L, Small GW, Conneally PM, Roses AD, et al. No association between alpha 1-antichymotrypsin and familial Alzheimer's disease. Annals of the New York Academy of Sciences. 802: 35-41. PMID 8993482 DOI: 10.1111/J.1749-6632.1996.Tb32596.X |
0.391 |
|
1996 |
Hyman BT, Gomez-Isla T, Rebeck GW, Briggs M, Chung H, West HL, Greenberg S, Mui S, Nichols S, Wallace R, Growdon JH. Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease. Annals of the New York Academy of Sciences. 802: 1-5. PMID 8993478 DOI: 10.1111/J.1749-6632.1996.Tb32592.X |
0.505 |
|
1996 |
Sano M, Ernesto C, Klauber MR, Schafer K, Woodbury P, Thomas R, Grundman M, Growdon J, Thal LJ. Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders. 10: 132-40. PMID 8876776 DOI: 10.1097/00002093-199601030-00004 |
0.387 |
|
1996 |
Growdon JH, Locascio JJ, Corkin S, Gomez-Isla T, Hyman BT. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology. 47: 444-8. PMID 8757018 DOI: 10.1212/Wnl.47.2.444 |
0.518 |
|
1996 |
Gómez-Isla T, Price JL, McKeel DW, Morris JC, Growdon JH, Hyman BT. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 4491-500. PMID 8699259 DOI: 10.1523/Jneurosci.16-14-04491.1996 |
0.462 |
|
1996 |
Hyman BT, Hedley-Whyte ET, Rebeck GW, Vonsattel JP, West HL, Growdon JH. Apolipoprotein E epsilon4/4 in a neuropathologically normal very elderly individual. Archives of Neurology. 53: 215. PMID 8651872 DOI: 10.1001/Archneur.1996.00550030017010 |
0.517 |
|
1996 |
Nitsch RM, Deng M, Growdon JH, Wurtman RJ. Serotonin 5-HT2a and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion. The Journal of Biological Chemistry. 271: 4188-94. PMID 8626761 DOI: 10.1074/jbc.271.8.4188 |
0.639 |
|
1996 |
Nitsch RM, Wurtman RJ, Growdon JH. Regulation of APP processing. Potential for the therapeutical reduction of brain amyloid burden. Annals of the New York Academy of Sciences. 777: 175-82. PMID 8624081 DOI: 10.1111/j.1749-6632.1996.tb34416.x |
0.661 |
|
1996 |
Hyman BT, Gomez-Isla T, West H, Briggs M, Chung H, Growdon JH, Rebeck GW. Clinical and neuropathological correlates of apolipoprotein E genotype in Alzheimer's disease. Window on molecular epidemiology. Annals of the New York Academy of Sciences. 777: 158-65. PMID 8624079 DOI: 10.1111/J.1749-6632.1996.Tb34414.X |
0.497 |
|
1996 |
Gomez-Isla T, West HL, Rebeck GW, Harr SD, Growdon JH, Locascio JJ, Perls TT, Lipsitz LA, Hyman BT. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease. Annals of Neurology. 39: 62-70. PMID 8572669 DOI: 10.1002/Ana.410390110 |
0.525 |
|
1996 |
Gomez-Isla T, Hollister R, West H, Mui S, Growdon JH, Pelersen RC, Parisi JE, Hyman BT. NEURONAL LOSS IN ALZHEIMERʼS DISEASE Journal of Neuropathology and Experimental Neurology. 55: 617. DOI: 10.1097/00005072-199605000-00058 |
0.432 |
|
1995 |
Nitsch RM, Wurtman RJ, Growdon JH. Regulation of proteolytic processing of the amyloid beta-protein precursor by first messengers. A novel potential approach for the treatment of Alzheimer's disease. Arzneimittel-Forschung. 45: 435-8. PMID 7763340 |
0.525 |
|
1995 |
Cronin-Golomb A, Corkin S, Growdon JH. Visual dysfunction predicts cognitive deficits in Alzheimer's disease. Optometry and Vision Science : Official Publication of the American Academy of Optometry. 72: 168-76. PMID 7609939 DOI: 10.1097/00006324-199503000-00004 |
0.316 |
|
1995 |
Mendola JD, Cronin-Golomb A, Corkin S, Growdon JH. Prevalence of visual deficits in Alzheimer's disease. Optometry and Vision Science : Official Publication of the American Academy of Optometry. 72: 155-67. PMID 7609938 DOI: 10.1097/00006324-199503000-00003 |
0.36 |
|
1995 |
Locascio JJ, Growdon JH, Corkin S. Cognitive test performance in detecting, staging, and tracking Alzheimer's disease. Archives of Neurology. 52: 1087-99. PMID 7487561 DOI: 10.1001/archneur.1995.00540350081020 |
0.389 |
|
1995 |
Farrer LA, Cupples LA, Van Duijn CM, Kurz A, Zimmer R, Müller U, Green RC, Clarke V, Shoffner J, Wallace DC, Chui H, Flanagan SD, Duara R, St. George-Hyslop P, Auerbach SA, ... ... Growdon JH, et al. Apolipoprotein E genotype in patients with Alzheimer's disease: Implications for the risk of dementia among relatives Annals of Neurology. 38: 797-808. PMID 7486872 DOI: 10.1002/Ana.410380515 |
0.354 |
|
1994 |
Keane MM, Gabrieli JD, Growdon JH, Corkin S. Priming in perceptual identification of pseudowords is normal in Alzheimer's disease. Neuropsychologia. 32: 343-56. PMID 8202228 DOI: 10.1016/0028-3932(94)90136-8 |
0.351 |
|
1994 |
Gabrieli JD, Keane MM, Stanger BZ, Kjelgaard MM, Corkin S, Growdon JH. Dissociations among structural-perceptual, lexical-semantic, and event-fact memory systems in Alzheimer, amnesic, and normal subjects. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 30: 75-103. PMID 8004991 DOI: 10.1016/S0010-9452(13)80325-5 |
0.356 |
|
1994 |
Cole DG, Growdon JH. Therapy for progressive supranuclear palsy: past and future. Journal of Neural Transmission. Supplementum. 42: 283-90. PMID 7964693 DOI: 10.1007/978-3-7091-6641-3_22 |
0.301 |
|
1994 |
Kurylo DD, Corkin S, Dolan RP, Rizzo JF, Parker SW, Growdon JH. Broad-band visual capacities are not selectively impaired in Alzheimer's disease. Neurobiology of Aging. 15: 305-11. PMID 7936054 DOI: 10.1016/0197-4580(94)90025-6 |
0.322 |
|
1994 |
Nitsch RM, Growdon JH. Role of neurotransmission in the regulation of amyloid beta-protein precursor processing. Biochemical Pharmacology. 47: 1275-84. PMID 7910457 DOI: 10.1016/0006-2952(94)90325-5 |
0.512 |
|
1994 |
Nitsch RM, Slack BE, Farber SA, Schulz JG, Deng M, Kim C, Borghesani PR, Korver W, Wurtman RJ, Growdon JH. Regulation of proteolytic processing of the amyloid beta-protein precursor of Alzheimer's disease in transfected cell lines and in brain slices. Journal of Neural Transmission. Supplementum. 44: 21-7. PMID 7897393 DOI: 10.1007/978-3-7091-9350-1_2 |
0.787 |
|
1994 |
Kurylo DD, Corkin S, Growdon JH. Perceptual organization in Alzheimer's disease. Psychology and Aging. 9: 562-7. PMID 7893427 DOI: 10.1037/0882-7974.9.4.562 |
0.301 |
|
1994 |
Farber S, Nitsch R, Growdon J, Wurtman R. 24. A novel approach to study the regulated release of secretory proteins from brain slices Journal of Neuroscience Methods. 52: A11-A12. DOI: 10.1016/0165-0270(94)90084-1 |
0.696 |
|
1993 |
Nitsch RM, Farber SA, Growdon JH, Wurtman RJ. Release of amyloid beta-protein precursor derivatives by electrical depolarization of rat hippocampal slices. Proceedings of the National Academy of Sciences of the United States of America. 90: 5191-3. PMID 8506366 DOI: 10.1073/PNAS.90.11.5191 |
0.719 |
|
1993 |
Kischka U, Mandir AS, Ghika J, Growdon JH. Electrophysiologic detection of extrapyramidal motor signs in Alzheimer's disease. Neurology. 43: 500-5. PMID 8450990 DOI: 10.1212/Wnl.43.3_Part_1.500 |
0.396 |
|
1993 |
Du W, DiLuca C, Growdon JH. Weight loss in Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology. 6: 34-8. PMID 8422270 DOI: 10.1177/002383099300600106 |
0.303 |
|
1993 |
Kurylo DD, Corkin S, Allard T, Zatorre RJ, Growdon JH. Auditory function in Alzheimer's disease. Neurology. 43: 1893-9. PMID 8413944 DOI: 10.1212/Wnl.43.10.1893 |
0.335 |
|
1993 |
Nitsch RM, Blusztajn JK, Doyle FM, Robitaille Y, Wurtman RJ, Growdon JH, Kish SJ. Phospholipid metabolite levels are altered in cerebral cortex of patients with dominantly inherited olivopontocerebellar atrophy. Neuroscience Letters. 161: 191-4. PMID 8272265 DOI: 10.1016/0304-3940(93)90291-R |
0.615 |
|
1993 |
Cronin-Golomb A, Sugiura R, Corkin S, Growdon JH. Incomplete achromatopsia in Alzheimer's disease. Neurobiology of Aging. 14: 471-7. PMID 8247229 DOI: 10.1016/0197-4580(93)90105-K |
0.365 |
|
1993 |
Nitsch RM, Slack BE, Farber SA, Borghesani PR, Schulz JG, Kim C, Felder CC, Growdon JH, Wurtman RJ. Receptor-coupled amyloid precursor protein processing. Annals of the New York Academy of Sciences. 695: 122-7. PMID 8239269 DOI: 10.1111/J.1749-6632.1993.Tb23039.X |
0.774 |
|
1993 |
Hung AY, Haass C, Nitsch RM, Qiu WQ, Citron M, Wurtman RJ, Growdon JH, Selkoe DJ. Activation of protein kinase C inhibits cellular production of the amyloid beta-protein. The Journal of Biological Chemistry. 268: 22959-62. PMID 8226807 |
0.488 |
|
1993 |
Gabrieli JD, Corkin S, Mickel SF, Growdon JH. Intact acquisition and long-term retention of mirror-tracing skill in Alzheimer's disease and in global amnesia. Behavioral Neuroscience. 107: 899-910. PMID 8136066 DOI: 10.1037/0735-7044.107.6.899 |
0.375 |
|
1993 |
Borgaonkar DS, Schmidt LC, Martin SE, Kanzer MD, Edelsohn L, Growdon J, Farrer LA. Linkage of late-onset Alzheimer's disease with apolipoprotein E type 4 on chromosome 19. Lancet. 342: 625. PMID 8102761 DOI: 10.1016/0140-6736(93)91458-X |
0.336 |
|
1992 |
Rizzo JF, Cronin-Golomb A, Growdon JH, Corkin S, Rosen TJ, Sandberg MA, Chiappa KH, Lessell S. Retinocalcarine function in Alzheimer's disease. A clinical and electrophysiological study. Archives of Neurology. 49: 93-101. PMID 1728270 DOI: 10.1001/Archneur.1992.00530250097023 |
0.359 |
|
1992 |
Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 42: 631-9. PMID 1549228 DOI: 10.1212/Wnl.42.3.631 |
0.5 |
|
1992 |
Nitsch RM, Slack BE, Wurtman RJ, Growdon JH. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science (New York, N.Y.). 258: 304-7. PMID 1411529 DOI: 10.1126/SCIENCE.1411529 |
0.732 |
|
1992 |
Cronin-Golomb A, Keane MM, Kokodis A, Corkin S, Growdon JH. Category knowledge in Alzheimer's disease: normal organization and a general retrieval deficit. Psychology and Aging. 7: 359-66. PMID 1388856 DOI: 10.1037//0882-7974.7.3.359 |
0.364 |
|
1992 |
Nitsch RM, Blusztajn JK, Pittas AG, Slack BE, Growdon JH, Wurtman RJ. Evidence for a membrane defect in Alzheimer disease brain. Proceedings of the National Academy of Sciences of the United States of America. 89: 1671-5. PMID 1311847 DOI: 10.1073/Pnas.89.5.1671 |
0.751 |
|
1992 |
Huff EJ, Growdon JH, Corkin S. Deterioration on the Blessed Information-Memory-Concentration Test in Alzheimer's disease. Psychiatry Research. 44: 167-8. PMID 1301042 DOI: 10.1016/0165-1781(92)90050-D |
0.32 |
|
1992 |
Nitsch RM, Slack BE, Wurtman RJ, Growdon JH. SECRETION OF ALZHEIMER AMYLOID PRECURSOR PROTEIN IS STIMULATED BY MUSCARINIC RECEPTOR ACTIVATION. Clinical Neuropharmacology. 15: 464B. DOI: 10.1097/00002826-199202001-00902 |
0.629 |
|
1991 |
Keane MM, Gabrieli JD, Fennema AC, Growdon JH, Corkin S. Evidence for a dissociation between perceptual and conceptual priming in Alzheimer's disease. Behavioral Neuroscience. 105: 326-42. PMID 2043276 DOI: 10.1037/0735-7044.105.2.326 |
0.346 |
|
1991 |
Farrer LA, Cupples LA, Connor L, Wolf PA, Growdon JH. Association of decreased paternal age and late-onset Alzheimer's disease. An example of genetic imprinting? Archives of Neurology. 48: 599-604. PMID 2039382 DOI: 10.1001/archneur.1991.00530180051017 |
0.386 |
|
1991 |
Cronin-Golomb A, Corkin S, Rizzo JF, Cohen J, Growdon JH, Banks KS. Visual dysfunction in Alzheimer's disease: relation to normal aging. Annals of Neurology. 29: 41-52. PMID 1996878 DOI: 10.1002/Ana.410290110 |
0.346 |
|
1991 |
Berry EM, Growdon JH, Wurtman JJ, Caballero B, Wurtman RJ. A balanced carbohydrate: protein diet in the management of Parkinson's disease. Neurology. 41: 1295-7. PMID 1866021 DOI: 10.1212/WNL.41.8.1295 |
0.629 |
|
1991 |
Cronin-Golomb A, Rizzo JF, Corkin S, Growdon JH. Visual function in Alzheimer's disease and normal aging. Annals of the New York Academy of Sciences. 640: 28-35. PMID 1776752 DOI: 10.1111/J.1749-6632.1991.Tb00186.X |
0.365 |
|
1991 |
Growdon JH, Nader TM, Schoenfeld J, Wurtman RJ. L-threonine in the treatment of spasticity. Clinical Neuropharmacology. 14: 403-12. PMID 1742749 DOI: 10.1097/00002826-199110000-00003 |
0.354 |
|
1991 |
Nitsch R, Pittas A, Blusztajn JK, Slack BE, Growdon JH, Wurtman RJ. Alterations of phospholipid metabolites in postmortem brain from patients with Alzheimer's disease. Annals of the New York Academy of Sciences. 640: 110-3. PMID 1663712 DOI: 10.1111/J.1749-6632.1991.Tb00200.X |
0.754 |
|
1990 |
Wurtman RJ, Blusztajn JK, Ulus IH, Coviella IL, Buyukuysal RL, Growdon JH, Slack BE. Choline metabolism in cholinergic neurons: implications for the pathogenesis of neurodegenerative diseases. Advances in Neurology. 51: 117-25. PMID 2403709 |
0.686 |
|
1990 |
Blusztajn JK, Lopez Gonzalez-Coviella I, Logue M, Growdon JH, Wurtman RJ. Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients. Brain Research. 536: 240-4. PMID 2150771 DOI: 10.1016/0006-8993(90)90030-F |
0.54 |
|
1989 |
de la Monte SM, Wells SE, Hedley-Whyte T, Growdon JH. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease. Annals of Neurology. 26: 309-20. PMID 2802531 DOI: 10.1002/ana.410260302 |
0.402 |
|
1989 |
Farrer LA, O'Sullivan DM, Cupples LA, Growdon JH, Myers RH. Assessment of genetic risk for Alzheimer's disease among first-degree relatives. Annals of Neurology. 25: 485-93. PMID 2774490 DOI: 10.1002/Ana.410250511 |
0.382 |
|
1989 |
Freed DM, Corkin S, Growdon JH, Nissen MJ. Selective attention in Alzheimer's disease: characterizing cognitive subgroups of patients. Neuropsychologia. 27: 325-39. PMID 2710323 DOI: 10.1016/0028-3932(89)90022-5 |
0.325 |
|
1989 |
Phelps CH, Gage FH, Growdon JH, Hefti F, Harbaugh R, Johnston MV, Khachaturian ZS, Mobley WC, Price DL, Raskind M. Potential use of nerve growth factor to treat Alzheimer's disease. Neurobiology of Aging. 10: 205-7. PMID 2657468 DOI: 10.1016/0197-4580(89)90032-8 |
0.523 |
|
1989 |
Sullivan EV, Sagar HJ, Gabrieli JD, Corkin S, Growdon JH. Different cognitive profiles on standard behavioral tests in Parkinson's disease and Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology. 11: 799-820. PMID 2592525 DOI: 10.1080/01688638908400937 |
0.392 |
|
1989 |
Wurtman RJ, Ulus IH, Blusztajn JK, Lopez-Coviella I, Agut J, Ortiz JA, Logue M, Mauron C, Growdon JH. Choline levels, the regulation of acetylcholine and phosphatidylcholine synthesis, and Alzheimer's disease Journal of Neural Transmission - Parkinson's Disease and Dementia Section. 1: 15. DOI: 10.1007/BF02312196 |
0.667 |
|
1988 |
Sagar HJ, Sullivan EV, Gabrieli JD, Corkin S, Growdon JH. Temporal ordering and short-term memory deficits in Parkinson's disease. Brain : a Journal of Neurology. 111: 525-39. PMID 3382911 DOI: 10.1093/Brain/111.3.525 |
0.355 |
|
1988 |
Sagar HJ, Cohen NJ, Sullivan EV, Corkin S, Growdon JH. Remote memory function in Alzheimer's disease and Parkinson's disease. Brain : a Journal of Neurology. 111: 185-206. PMID 3365547 DOI: 10.1093/Brain/111.1.185 |
0.345 |
|
1988 |
Johnson KA, Holman BL, Mueller SP, Rosen TJ, English R, Nagel JS, Growdon JH. Single photon emission computed tomography in Alzheimer's disease. Abnormal iofetamine I 123 uptake reflects dementia severity. Archives of Neurology. 45: 392-6. PMID 3258512 DOI: 10.1001/Archneur.1988.00520280038013 |
0.361 |
|
1988 |
Freed DM, Corkin S, Growdon JH, Nissen MJ. Selective attention in Alzheimer's disease: CSF correlates of behavioral impairments. Neuropsychologia. 26: 895-902. PMID 2461537 DOI: 10.1016/0028-3932(88)90057-7 |
0.349 |
|
1987 |
Huff FJ, Growdon JH, Corkin S, Rosen TJ. Age at onset and rate of progression of Alzheimer's disease. Journal of the American Geriatrics Society. 35: 27-30. PMID 3794143 DOI: 10.1111/J.1532-5415.1987.Tb01315.X |
0.371 |
|
1987 |
St George-Hyslop PH, Tanzi RE, Polinsky RJ, Neve RL, Pollen D, Drachman D, Growdon J, Cupples LA, Nee L, Myers RH. Absence of duplication of chromosome 21 genes in familial and sporadic Alzheimer's disease. Science (New York, N.Y.). 238: 664-6. PMID 2890206 DOI: 10.1126/Science.2890206 |
0.377 |
|
1986 |
Miatto O, Gonzalez RG, Buonanno F, Growdon JH. In vitro 31P NMR spectroscopy detects altered phospholipid metabolism in Alzheimer's disease. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 13: 535-9. PMID 3791069 DOI: 10.1017/S0317167100037276 |
0.383 |
|
1986 |
Huff FJ, Growdon JH. Neurological abnormalities associated with severity of dementia in Alzheimer's disease. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 13: 403-5. PMID 3791053 DOI: 10.1017/S0317167100036970 |
0.376 |
|
1986 |
Mazurek MF, Growdon JH, Beal MF, Martin JB. CSF vasopressin concentration is reduced in Alzheimer's disease. Neurology. 36: 1133-7. PMID 3736884 DOI: 10.1212/Wnl.36.8.1133 |
0.36 |
|
1986 |
Huff FJ, Corkin S, Growdon JH. Semantic impairment and anomia in Alzheimer's disease. Brain and Language. 28: 235-49. PMID 3730816 DOI: 10.1016/0093-934X(86)90103-3 |
0.345 |
|
1986 |
Huff FJ, Maire JC, Growdon JH, Corkin S, Wurtman RJ. Cholinesterases in cerebrospinal fluid. Correlations with clinical measures in Alzheimer's disease. Journal of the Neurological Sciences. 72: 121-9. PMID 3711929 DOI: 10.1016/0022-510X(86)90001-8 |
0.681 |
|
1986 |
Growdon JH, Corkin S, Huff FJ, Rosen TJ. Piracetam combined with lecithin in the treatment of Alzheimer's disease. Neurobiology of Aging. 7: 269-76. PMID 3528889 DOI: 10.1016/0197-4580(86)90007-2 |
0.349 |
|
1986 |
Beal MF, Growdon JH. CSF neurotransmitter markers in Alzheimer's disease. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 10: 259-70. PMID 2879317 DOI: 10.1016/0278-5846(86)90006-0 |
0.4 |
|
1986 |
Beal MF, Growdon JH, Mazurek MF, Martin JB. CSF somatostatin-like immunoreactivity in dementia. Neurology. 36: 294-7. PMID 2868429 DOI: 10.1212/Wnl.36.2.294 |
0.422 |
|
1986 |
Sullivan EV, Corkin S, Growdon JH. Verbal and Nonverbal Short-Term Memory in Patients With Alzheimer's Disease and in Healthy Elderly Subjects Developmental Neuropsychology. 2: 387-400. DOI: 10.1080/87565648609540356 |
0.357 |
|
1985 |
Lieberman HR, Corkin S, Spring BJ, Wurtman RJ, Growdon JH. The effects of dietary neurotransmitter precursors on human behavior. The American Journal of Clinical Nutrition. 42: 366-70. PMID 4025206 DOI: 10.1093/ajcn/42.2.366 |
0.555 |
|
1985 |
Logue MP, Growdon JH, Coviella IL, Wurtman RJ. Differential effects of DSP-4 administration on regional brain norepinephrine turnover in rats. Life Sciences. 37: 403-9. PMID 4021721 DOI: 10.1016/0024-3205(85)90401-1 |
0.464 |
|
1985 |
Gibson CJ, Logue M, Growdon JH. CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease. Archives of Neurology. 42: 489-92. PMID 2581531 DOI: 10.1001/archneur.1985.04060050091016 |
0.582 |
|
1984 |
Lieberman HR, Corkin S, Spring BJ, Garfield GS, Growdon JH, Wurtman RJ. The effects of tryptophan and tyrosine on human mood and performance. Psychopharmacology Bulletin. 20: 595-8. PMID 6473667 |
0.336 |
|
1984 |
Zubenko GS, Cohen BM, Growdon J, Corkin S. Cell membrane abnormality in Alzheimer's disease. Lancet (London, England). 2: 235. PMID 6146798 DOI: 10.1016/S0140-6736(84)90528-2 |
0.348 |
|
1983 |
Corkin S, Growdon JH, Rasmussen SL. Parental age as a risk factor in Alzheimer's disease. Annals of Neurology. 13: 674-6. PMID 6881929 DOI: 10.1002/ana.410130618 |
0.358 |
|
1983 |
Growdon JH. Neuropharmacology of degenerative diseases associated with aging. Medicinal Research Reviews. 3: 237-57. PMID 6136638 DOI: 10.1002/Med.2610030303 |
0.303 |
|
1982 |
Canter NL, Hallett M, Growdon JH. Lecithin does not affect EEG spectral analysis or P300 in Alzheimer disease. Neurology. 32: 1260-6. PMID 6890160 DOI: 10.1212/Wnl.32.11.1260 |
0.333 |
|
1982 |
Lieberman HR, Corkin S, Spring BJ, Growdon JH, Wurtman RJ. Mood, performance, and pain sensitivity: changes induced by food constituents. Journal of Psychiatric Research. 17: 135-45. PMID 6764930 DOI: 10.1016/0022-3956(82)90015-2 |
0.534 |
|
1982 |
Growdon JH, Melamed E, Logue M, Hefti F, Wurtman RJ. Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease. Life Sciences. 30: 827-32. PMID 6175872 DOI: 10.1016/0024-3205(82)90596-3 |
0.671 |
|
1982 |
Reinstein D, Corkin S, Growdon JH, Wurtman RJ, Zeisel SH. The second meeting of the international study group on the pharmacology of memory disorders associated with aging (ISG) Neuropsychologia. 20: 225-226. DOI: 10.1016/0028-3932(82)90015-X |
0.555 |
|
1981 |
Zeisel S, Reinstein D, Corkin S, Growdon J, Wurtman R. Cholinergic neurones and memory. Nature. 293: 187-8. PMID 7278975 DOI: 10.1038/293187a0 |
0.553 |
|
1981 |
Wurtman JJ, Wurtman RJ, Growdon JH, Henry P, Lipscomb A, Zeisel SH. Carbohydrate craving in obese people: Suppression by treatments affecting serotoninergic transmission International Journal of Eating Disorders. 1: 2-15. DOI: 10.1002/1098-108X(198123)1:1<2::AID-EAT2260010102>3.0.CO;2-Q |
0.427 |
|
1980 |
Gelenberg AJ, Wojcik JD, Growdon JH, Sved AF, Wurtman RJ. Tyrosine for the treatment of depression. The American Journal of Psychiatry. 137: 622-3. PMID 7369415 DOI: 10.1176/AJP.137.5.622 |
0.56 |
|
1980 |
Zeisel SH, Growdon JH, Wurtman RJ, Magil SG, Logue M. Normal plasma choline responses to ingested lecithin. Neurology. 30: 1226-9. PMID 7191517 DOI: 10.1212/WNL.30.11.1226 |
0.559 |
|
1980 |
Melamed E, Glaeser B, Growdon JH, Wurtman RJ. Plasma tyrosine in normal humans: effects of oral tyrosine and protein-containing meals. Journal of Neural Transmission. 47: 299-306. PMID 7190187 DOI: 10.1007/BF01247323 |
0.573 |
|
1980 |
Zeisel SH, Gelenberg AJ, Growdon JH, Wurtman RJ. Use of choline and lecithin in the treatment of tardive dyskinesia. Advances in Biochemical Psychopharmacology. 24: 463-70. PMID 6996444 |
0.374 |
|
1979 |
Glaeser BS, Melamed E, Growdon JH, Wurtman RJ. Elevation of plasma tyrosine after a single oral dose of L-tyrosine. Life Sciences. 25: 265-71. PMID 481129 DOI: 10.1016/0024-3205(79)90294-7 |
0.539 |
|
1979 |
Growdon JH, Wurtman RJ. Dietary influences on the synthesis of neurotransmitters in the brain. Nutrition Reviews. 37: 129-36. PMID 40170 DOI: 10.1111/J.1753-4887.1979.TB06649.X |
0.349 |
|
1978 |
Hirsch MJ, Growdon JH, Wurtman RJ. Relations between dietary choline or lecithin intake, serum choline levels, and various metabolic indices. Metabolism: Clinical and Experimental. 27: 953-60. PMID 672614 DOI: 10.1016/0026-0495(78)90139-7 |
0.471 |
|
1978 |
Sahakian BJ, Growdon JH, Millington WR, Barr JK, Wurtman RJ. The effects of cholinergic agonists on apomorphine-induced stereotyped behavior in the rat. Communications in Psychopharmacology. 2: 255-62. PMID 568059 |
0.328 |
|
1978 |
Wurtman RJ, Growdon JH. Dietary enhancement of CNS neurotransmitters. Hospital Practice. 13: 71-7. PMID 147851 DOI: 10.1080/21548331.1978.11707296 |
0.484 |
|
1977 |
Growdon JH, Hirsch MJ, Wurtman RJ, Wiener W. Oral choline administration to patients with tardive dyskinesia. The New England Journal of Medicine. 297: 524-7. PMID 887103 DOI: 10.1056/NEJM197709082971002 |
0.477 |
|
1977 |
Hirsch MJ, Growdon JH, Wurtman RJ. Increase in hippocampal acetylcholine after choline administration. Brain Research. 125: 383-5. PMID 851886 DOI: 10.1016/0006-8993(77)90634-5 |
0.429 |
|
1977 |
Growdon JH, Cohen EL, Wurtman RJ. Huntington's disease: clinical and chemical effects of choline administration. Annals of Neurology. 1: 418-22. PMID 152596 DOI: 10.1002/ana.410010503 |
0.453 |
|
1977 |
Growdon JH, Cohen EL, Wurtman RJ. Effects of oral choline administration on serum and CSF choline levels in patients with Huntington's disease. Journal of Neurochemistry. 28: 229-31. PMID 137960 DOI: 10.1111/j.1471-4159.1977.tb07732.x |
0.494 |
|
1977 |
Wurtman RJ, Hirsch MJ, Growdon JH. Lecithin consumption raises serum-free-choline levels. Lancet (London, England). 2: 68-9. PMID 69151 DOI: 10.1016/S0140-6736(77)90067-8 |
0.37 |
|
1977 |
Growdon JH, Cohen EL, Wurtman RJ. Treatment of brain disease with dietary precursors of neurotransmitters. Annals of Internal Medicine. 86: 337-9. PMID 14577 DOI: 10.7326/0003-4819-86-3-337 |
0.492 |
|
Show low-probability matches. |